TY - JOUR
T1 - Testing the effects of gentle vibrotactile stimulation on symptom relief in fibromyalgia
AU - Pujol, Jesus
AU - Ramos-López, Daniel
AU - Blanco-Hinojo, Laura
AU - Pujol, Guillem
AU - Ortiz, Héctor
AU - Martínez-Vilavella, Gerard
AU - Blanch, Josep
AU - Monfort, Jordi
AU - Deus, Joan
PY - 2019/6/14
Y1 - 2019/6/14
N2 - © 2019 The Author(s). Background: Sensory disturbances in fibromyalgia extend beyond nociception. It has been proposed that imbalance in the mutual competition between painful input and non-painful sensory activity may, to a significant extent, account for the augmented subjective perception of pain. In this context, non-nociceptive somatosensory stimulation could arguably attenuate fibromyalgia symptoms by restoring the sensory balance. We specifically tested the effect of vibrotactile stimulation on symptom relief in fibromyalgia patients with a randomized, double-blind, sham-controlled, crossover clinical trial. Methods: Seventy-seven female patients were randomized and data from 63 valid cases were analyzed. Active intervention involved extensive body stimulation with gentle mechanical vibrations administered during 3 h at night for 3 weeks, and the placebo effect was controlled using identical instruments to simulate an alternative treatment option. The primary outcome measure combined pain, fatigue, and complaints of poor cognition. Results: Vibrotactile stimulation was significantly superior to sham in alleviating fibromyalgia symptoms globally. However, univariate analyses showed that the effect was not universal. Benefits were perceived on unpleasant somatic sensations such as generalized pain and fatigue, but not on poor cognition, anxiety, and depression. Vibrotactile stimulation was notably well tolerated and sleep quality significantly improved despite the fact that vibrations were administered at night. Conclusions: Results thus provide new evidence that non-nociceptive somatosensory stimulation may favorably act upon altered somatosensory balance in fibromyalgia. From a clinical perspective, both the degree of improvement and the easy application of our proposal would seem to support a potential role for vibrotactile stimulation in the symptomatic treatment of fibromyalgia. Trial registration: ClinicalTrials.gov registration number NCT03227952. Registered 24 July, 2017.
AB - © 2019 The Author(s). Background: Sensory disturbances in fibromyalgia extend beyond nociception. It has been proposed that imbalance in the mutual competition between painful input and non-painful sensory activity may, to a significant extent, account for the augmented subjective perception of pain. In this context, non-nociceptive somatosensory stimulation could arguably attenuate fibromyalgia symptoms by restoring the sensory balance. We specifically tested the effect of vibrotactile stimulation on symptom relief in fibromyalgia patients with a randomized, double-blind, sham-controlled, crossover clinical trial. Methods: Seventy-seven female patients were randomized and data from 63 valid cases were analyzed. Active intervention involved extensive body stimulation with gentle mechanical vibrations administered during 3 h at night for 3 weeks, and the placebo effect was controlled using identical instruments to simulate an alternative treatment option. The primary outcome measure combined pain, fatigue, and complaints of poor cognition. Results: Vibrotactile stimulation was significantly superior to sham in alleviating fibromyalgia symptoms globally. However, univariate analyses showed that the effect was not universal. Benefits were perceived on unpleasant somatic sensations such as generalized pain and fatigue, but not on poor cognition, anxiety, and depression. Vibrotactile stimulation was notably well tolerated and sleep quality significantly improved despite the fact that vibrations were administered at night. Conclusions: Results thus provide new evidence that non-nociceptive somatosensory stimulation may favorably act upon altered somatosensory balance in fibromyalgia. From a clinical perspective, both the degree of improvement and the easy application of our proposal would seem to support a potential role for vibrotactile stimulation in the symptomatic treatment of fibromyalgia. Trial registration: ClinicalTrials.gov registration number NCT03227952. Registered 24 July, 2017.
KW - CRITERIA
KW - DEPRESSION
KW - FATIGUE
KW - FUNCTIONAL CONNECTIVITY
KW - Fibromyalgia
KW - HOSPITAL ANXIETY
KW - PAIN CLINICAL-TRIALS
KW - Pain
KW - Sensory balance
KW - Somatosensory system
KW - Vibrotactile stimulation
KW - WOMEN
UR - http://www.mendeley.com/research/testing-effects-gentle-vibrotactile-stimulation-symptom-relief-fibromyalgia
U2 - https://doi.org/10.1186/s13075-019-1932-9
DO - https://doi.org/10.1186/s13075-019-1932-9
M3 - Article
C2 - 31200775
VL - 21
SP - 148
JO - Arthritis Research and Therapy
JF - Arthritis Research and Therapy
SN - 1478-6354
IS - 1
M1 - 148
ER -